tiprankstipranks
Enzon Pharmaceuticals (ENZND)
OTHER OTC:ENZND
US Market
ENZND
Enzon Pharmaceuticals
RESEARCH TOOLSreports
Want to see ENZND full AI Analyst Report?

Enzon Pharmaceuticals (ENZND) Income Statement

92 Followers

Enzon Pharmaceuticals Income Statement

Last quarter (Q4 2025), Enzon Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Enzon Pharmaceuticals's net income was $-1.07M. See Enzon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 26.00K$ 0.00$ 26.00K$ 701.00K
Gross Profit
$ 0.00$ 26.00K$ 0.00$ 26.00K$ 701.00K
Operating Expenses
$ 1.36M$ 1.35M$ 1.04M$ 1.06M$ 1.17M
Depreciation and Amortization
$ 0.00$ 1.33M$ 2.26M$ 1.03M$ 469.00K
EBITDA
$ -1.36M$ 0.00$ 3.48M$ 0.00$ 0.00
Operating Income
$ -1.36M$ -1.33M$ -1.04M$ -1.03M$ -469.00K
Other Income/Expenses
$ -2.03M$ 2.45M$ 2.26M$ 646.00K$ 7.00K
Pretax Income
$ -3.39M$ 1.13M$ 1.22M$ -386.00K$ -462.00K
Net Income
$ -3.41M$ 778.00K$ 98.00K$ -186.00K$ -469.00K
Per Share Metrics
Basic EPS
$ -7.46$ -0.67$ 0.13$ -2.00$ -3.00
Diluted EPS
$ -7.46$ -0.67$ 0.13$ -2.00$ -3.00
Weighted Average Shares Outstanding
 742.15K 742.15K 742.42K 742.15K 742.15K
Weighted Average Shares Outstanding (Diluted)
 742.15K 742.15K 742.15K 742.15K 742.15K
Currency in USD

Enzon Pharmaceuticals Earnings and Revenue History